The trial included patients with poorly controlled hypertension, hyperlipidemia, diabetes.
A behavioral-based remote intervention may help increase medication adherence in patients with certain conditions, researchers reported.
Patients with hyperlipidemia, hypertension, and diabetes increased their medication adherence by 4.7% (95% CI 3.0%-6.4%) when placed into a pharmacist-led multicomponent, behaviorally-tailored intervention compared with those receiving usual care, reported Niteesh Choudhry, MD, Ph.D., of Brigham and Women’s Hospital in Boston, and colleagues.
The intervention program was led by pharmacists and began with a consultation via telephone in order to individually tailor each patient’s care. The program included several strategies related to patients’ willingness to modify behaviors and barriers to adherence, which included structured consultation reports sent to the patients’ primary care physicians along with recommendations for treatment modifications and coordination of care. The intervention also included strategies aimed at promoting medication adherence, such as sending text messages and using pillboxes, as well as establishing follow-up consultation with the pharmacist.
